Integra LifeSciences Holdings Corporation
IART
$13.57
$0.564.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.55% | 16.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.55% | 16.23% | |||
| Cost of Revenue | -5.26% | 8.61% | |||
| Gross Profit | -19.07% | 21.92% | |||
| SG&A Expenses | -7.73% | 4.84% | |||
| Depreciation & Amortization | -0.30% | -1.20% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.18% | 6.36% | |||
| Operating Income | -51.06% | 155.98% | |||
| Income Before Tax | -233.25% | 210.70% | |||
| Income Tax Expenses | -252.70% | 132.13% | |||
| Earnings from Continuing Operations | -230.14% | 281.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -230.14% | 281.72% | |||
| EBIT | -51.06% | 155.98% | |||
| EBITDA | -37.01% | 132.49% | |||
| EPS Basic | -230.08% | 281.77% | |||
| Normalized Basic EPS | -63.05% | 259.55% | |||
| EPS Diluted | -230.85% | 280.57% | |||
| Normalized Diluted EPS | -63.05% | 259.55% | |||
| Average Basic Shares Outstanding | 0.06% | -0.04% | |||
| Average Diluted Shares Outstanding | 0.06% | -0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||